Stanley T. Crooke, M.D., Ph.D.
Chairman of the Board and Chief Executive Officer, Isis Pharmaceuticals, Inc.Stanley T. Crooke, M.D., Ph.D.
Chairman of the Board and Chief Executive Officer, Isis Pharmaceuticals, Inc.
Untitled Document
Dr. Crooke is Founder, Chairman and Chief Executive Officer of Isis Pharmaceuticals. Isis is a development stage biopharmaceutical company that is focused on a new paradigm in drug discovery, antisen... |
|
 |
Spencer R. Berthelsen, M.D.
Chairman and Managing Director, Kelsey-Seybold ClinicSpencer R. Berthelsen, M.D.
Chairman and Managing Director, Kelsey-Seybold Clinic
Dr. Berthelsen has served as a Director of Isis since May 2002. Since 1980, he has practiced Internal Medicine with the Kelsey Seybold Clinic, a 370 physician medical group based in the Texas Medical Center in Houston. Dr. Berthelsen has served in various senior leadership positions at Kelsey Seybold, including Chairman of the Department of Internal Medicine, Medical Director and Managing Director. He has been Chairman of their Board of Directors since October 2001. He has served as a Clinic... |
|
|
Joseph Klein, III
Managing Director, Gauss Capital Advisors, LLCJoseph Klein, III
Managing Director, Gauss Capital Advisors, LLC
Mr. Klein has served as a Director of Isis since December 2005. Mr. Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998. From September 2003 to December 2008, Mr. Klein also served as a Venture Partner of Red Abbey Venture Partners, L.P., a life science private equity fund. From September 2001 to September 2002, Mr. Klein was a Venture Partner of MPM Capital, a he... |
|
|
Frederick T. Muto, Esq.*
Partner, Cooley LLPFrederick T. Muto, Esq.*
Partner, Cooley LLP
Frederick T. Muto has served as a Director of Isis since March 2001. Mr. Muto joined the law firm of Cooley LLP, outside counsel to Isis, in 1980 and became a partner in 1986. He is Chair of the firm's Business Department, a founding partner of Cooley LLP's San Diego office and serves on Cooley's management committee.... |
|
|
B. Lynne Parshall, Esq.
Director, Chief Operating Officer & Chief Financial Officer, Isis Pharmaceuticals, Inc.B. Lynne Parshall, Esq.
Director, Chief Operating Officer & Chief Financial Officer, Isis Pharmaceuticals, Inc.
Ms. Parshall is Director, Chief Operating Officer and Chief Financial Officer of Isis Pharmaceuticals. She is responsible for overseeing the operations of finance, legal, patents, manufacturing, and business development and is also very involved in the Company’s corporate communications activities. Ms. Parshall joined Isis in November 1991.
Previously, Ms. Parshall was a Partner with the firm of Cooley Godward LLP, now Cooley LLP, where she represented several health care ... |
|
|
John C. Reed, M.D., Ph.D.
Chief Executive Officer, Professor and Donald Bren Chief Executive Chair, Sanford-Burnham Medical Research InstituteJohn C. Reed, M.D., Ph.D.
Chief Executive Officer, Professor and Donald Bren Chief Executive Chair, Sanford-Burnham Medical Research Institute
Dr. Reed has served as a Director of Isis since February 2002. Dr. Reed served as the President and Chief Executive Officer since January 2002, and in 2010 he became CEO, Professor, and Donald Bren Chief Executive Chair, of Sanford-Burnham Medical Research Institute, an independent, nonprofit, public benefit organization dedicated to biomedical research. Dr. Reed has been with Sanford-Burnham Medical Research Institute for the past 19 years, serving as the Deputy Director of the Cancer Center ... |
|
|
Joseph H. Wender
Senior Consultant, Goldman Sachs & Co.Joseph H. Wender
Senior Consultant, Goldman Sachs & Co.
Mr. Wender has served as a Director of Isis since January 1994. Mr. Wender began with Goldman, Sachs & Co. in 1971 and became a General Partner of that firm in 1982, where he headed the Financial Institutions Group for over a decade. Since January 2008, he has been a Senior Consultant to Goldman Sachs & Co. He is also an Independent Trustee of the Schwab Family of Funds and Director of Grandpoint Capital, a bank holding company.... |
|
|
